Skip to main content

01-09-2016 | Neuroendocrine tumors | Book chapter | Article

Targeted Therapies for Neuroendocrine Neoplasms

Authors: MD, PhD Heloisa Prado Soares, MD Jonathan Strosberg

Publisher: Springer New York


Neuroendocrine tumors are rare but have increased in incidence over the last several decades. Significant advances in the understanding of the molecular biology of these tumors have led to new treatment options. Somatostatin analogs were the first targeted therapy for neuroendocrine tumors. Several other targeted therapies have subsequently established a role in the management of these diseases. In this chapter, we will describe currently available targeted therapies for neuroendocrine tumors and review the clinical status of promising investigational therapies.

Please log in to get access to this content

Related topics